Design Therapeutics is pioneering novel small-molecule therapeutic candidates, called gene targeted chimeras (GeneTACs™), designed to be disease-modifying and target the underlying cause of inherited nucleotide repeat expansion diseases.



Education

Pharmaceutical

Design Therapeutics

Design Therapeutics' headquarters in Carlsbad, CA, United States

Sean Jeffries

James Gomez

Julie Burgess

Nancy Levin

Aaron Young

Jim Kerr

Laura Weston

Mustapha Parekh

Mark Daniels

Sam Moskowitz M.D.

Justine Latimer (Haynes)

Haiyan Tao

Lisa Jo Reboton

Melanie Bell

Hannah Han

Howah Hung

Stella Xu

Aseem Z. Ansari

Arsani William

Rodney Lappe

Pratik Shah

Deepa Prasad

Heather Berger

The Research and Development team at Design Therapeutics focuses on pioneering novel small-molecule therapeutic candidates, specifically GeneTACs™, to modify diseases by targeting the underlying causes of inherited nucleotide repeat expansion diseases. This multidisciplinary team, comprising bioinformatics experts, computational chemists, and biologists, works collaboratively to design, synthesize, and evaluate the efficacy of these therapeutics through advanced research and innovative drug discovery techniques.

Research and Development

The Product Development and Management Team at Design Therapeutics is responsible for overseeing the progression of novel small-molecule therapeutic candidates, GeneTACs™, from conceptualization through clinical development. This team develops strategic plans, coordinates research and lab operations, manages clinical trials, and ensures that products are developed in compliance with regulatory standards, all aimed at addressing inherited nucleotide repeat expansion diseases.

Product Development and Management Team

The Directors Team at Design Therapeutics is responsible for setting strategic direction, overseeing key projects, and ensuring alignment across various departments to advance the development of GeneTACs™. They collaborate to make high-level decisions, manage organizational goals, and drive the company's mission to address the root causes of inherited nucleotide repeat expansion diseases.

Directors Team

The Accounting and Finance Team at Design Therapeutics is responsible for managing the company’s financial health and ensuring regulatory compliance. This includes overseeing financial reporting, budgeting, audits, and strategic financial planning to support the development of GeneTACs™ and drive the company’s mission forward.

Accounting and Finance Team

The Leadership Team at Design Therapeutics drives the strategic vision and operational excellence of the company, guiding the development of innovative GeneTACs™ to effectively target and modify the underlying causes of inherited nucleotide repeat expansion diseases. With a blend of entrepreneurial spirit and operational expertise, this team fosters collaboration, aligns resources, and ensures the successful advancement of therapeutic candidates through clinical development.

Leadership Team

The Legal & HR Team at Design Therapeutics ensures compliance with regulatory standards, manages intellectual property, and oversees all legal matters related to R&D. Additionally, the team focuses on employee well-being, recruitment, and development, fostering a supportive and legally sound work environment.

Legal & HR Team

Design Therapeutics

Org chart

Board & advisors

Teams

Research and Development

Product Development and Management Team

Directors Team

Accounting and Finance Team

Leadership Team

Legal & HR Team

Offices

Design Therapeutics

Org chart

Board & advisors

Teams

Research and Development

Product Development and Management Team

Directors Team

Accounting and Finance Team

Leadership Team

Legal & HR Team

Offices

Related companies